Currently predicting for Thu, 4 Jun 2026

GNPX Prediction Chart

GNPX Predictions History

Latest community submissions for GNPX.
Predictor Target Session Target Price Result Direction Accuracy Score
Oct 31, 2025 Bullish $5.77 X 0
Oct 29, 2025 $8.86 +26.81% $6.64 X 66.50% 0
Oct 29, 2025 $8.16 +16.76% $6.64 X 77.09% 0
Oct 29, 2025 $9.00 +28.76% $6.64 X 64.46% 0
Oct 28, 2025 $10.67 +21.92% $6.99 X 47.39% 0
Oct 28, 2025 $9.95 +13.70% $6.99 X 57.67% 0
Oct 28, 2025 $12.00 +37.14% $6.99 X 28.33% 0
Oct 27, 2025 $11.65 +21.18% $8.75 X 66.91% 0
Oct 27, 2025 $10.88 +13.24% $8.75 X 75.63% 0
Oct 27, 2025 $12.00 +24.87% $8.75 X 62.86% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for GNPX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT GENPREX INC.
Genprex
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas....
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE